Document ID: chunk:federal_register_of_legislation:F2024C00918:body:0:p2
Version: federal_register_of_legislation:F2024C00918
Segment Type: other
Provision Reference: 
Character Range: 2467–5881

food in Australia or New Zealand.
                                              (2) Any of the following:

                  (a) the presence of a food in a food for special medical purposes;

                  (b)  the presence of a food in a special medical purpose product for infants;

                  (c) the use of a food as a food for special medical purpose;

                  (d) the use of a food as a special medical purpose product for infants;

             do not constitute a history of human consumption in Australia or New Zealand in relation to that food for the purposes of this section.

1.5.1—3 Sale of novel foods
 (1) Despite paragraphs 1.1.1—10(5)(b) and (6)(f), a food offered for retail sale (other than an infant formula product) may consist of, or have as an ingredient, a *novel food if:
 (a) the novel food is listed in the table to section S25—2; and
 (b) any conditions of use specified in the corresponding row of that table are complied with.
 Note Novel foods are added to the table to section S25—2 by variations to the Code. When added for the first time, the conditions may include some that apply to the novel food only during the first 15 months after gazettal of the variation. Conditions may also deal with matters such as the following:
 · the need for preparation or cooking instructions, warning statements or other advice;
 · the need to meet specific requirements of composition or purity;
 · the class of food within which the food must be sold;
 · during the first 15 months after gazettal, the brand under which the food may be sold.
            (2) Despite paragraphs 1.1.1—10(5)(b) and (6)(f), an infant formula product for retail sale may consist of, or have as an ingredient or a *component, a novel food only if:
 (a) the novel food is listed in the table to section S25—2; and
 (b) the presence of that novel food in the infant formula product is expressly permitted by that table; and
 (c) any conditions of use specified in the corresponding row of that table are complied with.
____________________

           Application, saving and transitional provisions

The table below details information on application, saving or transitional provisions in instruments affecting this Standard.

Instrument items affected                                                                       A'ment No.  FRLI registration  Instrument's transitional provision  Description of transitional arrangement
                                                                                                            Gazette
Food Standards (Proposal P1028 – Infant Formula Products – Consequential Amendments) Variation
Items [13] and [13A] of Schedule 2                                                              231         F2024L01151        Clause 4                             Clause 4 establishes a transitional arrangement for variations to the Code made by Items [13] and [13A] of Schedule 2 and by the Food Standards (Proposal P1028 – Infant Formula Products – Consequential Amendments) Variation.
                                                                                                            13 Sept 2024
                                                                                                            FSC 171                                                 The transition period is the period of time that commences on 13 September